Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
SHH: 688505.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Da Jun Zhao
- Employees
- 921
- Headquarters
- Shanghai, China
- IPO year
- 2020
- Market cap
- CN¥922.8M
- Website
- https://www.fd-zj.com
Loading 688505…
Loading profile data…Frequently asked questions about 688505
What does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) do?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-DM1 antibody-drug conjugate (ADC), which is in Phase I clinical trials for tumors; Trop2-SN38 ADC that is in Phase I clinic...
Where does 688505.SS trade?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) trades on the Shanghai Stock Exchange.
What sector is 688505.SS in?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.?
Da Jun Zhao is the chief executive officer of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS).
Where is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. headquartered?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. is headquartered in China.
Does 688505.SS pay a dividend?
Yes — Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) paid a trailing twelve-month dividend of CNY 0.03 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688505.SS go public?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) completed its initial public offering in 2020.